Outcome of Primary Prevention Implantable Cardioverter Defibrillator Therapy According to New York Heart Association Functional Classification.
Providência R, Boveda S, Defaye P, Segal O, Algalarrondo V, Sadoul N, Lambiase P, Piot O, Klug D, Perier MC, Bouzeman A, Barra S, Bories MC, Gras D, Fauchier L, Bordachar P, Babuty D, Deharo JC, Leclercq C, Marijon E; DAI-PP Investigators.
Providência R, et al. Among authors: bouzeman a.
Am J Cardiol. 2016 Oct 15;118(8):1225-1232. doi: 10.1016/j.amjcard.2016.07.037. Epub 2016 Jul 29.
Am J Cardiol. 2016.
PMID: 27561197